奧瑞金(002701.SZ)擬向控股股東1.462億元購買浦東新區一處房產
格隆匯7月10日丨奧瑞金(002701.SZ)公佈,為滿足公司業務發展需要,公司擬使用自有資金購買控股股東上海原龍位於上海市浦東新區五星路676弄的3幢房屋,建築面積3182.73㎡,房屋用途為科研設計。經雙方協商一致,本次交易總價為人民幣1.462億元。
為配合業務管理中心和創新事業部更好地行使職能,擬將現位於湖北咸寧的奧瑞金包裝博物館及產品展示中心遷建至上海,針對行業發展趨勢和消費文化升級,開展綠色環保包裝、包裝材料循環利用、智能包裝等領域的技術交流、培訓和合作活動,樹立行業文化標杆,提升公司品牌影響力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.